COMMUNIQUÉS West-GlobeNewswire

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
08/07/2026
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 08 juillet 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
Bilan semestriel du contrat de liquidité avec Invest Securities
08/07/2026
NANTES, France, le 8 juillet 2026, 18h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) – Au titre du contrat de liquidité confié par OSE Immunotherapeutics à Invest Securities, les moyens suivants [...]
Half-Year Report on Liquidity Contract with Invest Securities
08/07/2026
NANTES, France, July 8, 2026 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) – Under the liquidity contract entrusted by OSE Immunotherapeutics to Invest Securities, the following resources [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
08/07/2026
Nantes, le 8 juillet 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]
Sienna Announces Second Quarter 2026 Results Release Date and Conference Call
08/07/2026
MARKHAM, Ontario, July 08, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2026 second quarter results after market close on Tuesday, [...]
SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1)
08/07/2026
Approximately $40 million in cash and more than $15 million in short-term investment assets as of June 30, 2026 1 Estimated net asset value of approximately $60 million and no debt outstanding as of June 30, 2026¹ [...]
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
08/07/2026
RUTHERFORD, N.J., July 08, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel [...]
Nordic Ranked No. 1 Overall in Black Book’s 2026 Healthcare IT Consulting and Advisory Services Report
08/07/2026
MADISON, Wis., July 08, 2026 (GLOBE NEWSWIRE) -- Nordic ® , a global health and technology consulting company, has been ranked No. 1 overall in Black Book Market Research's 2026 Healthcare IT Consulting & Advisory [...]
UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer
08/07/2026
FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient enrollment expected to begin in Q4 2026 UGN-501 is a differentiated [...]
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics
08/07/2026
-- Arbitration tribunal declared that PM647 is within Prime Medicine’s “Field”, confirming Prime Medicine’s right to develop and commercialize PM647 in AATD -- -- Prime Medicine owes no monetary damages to Beam [...]
GeneCentric Launches ExpressCT Rewind™ to Unlock Gene Expression Insights from Existing Liquid Biopsy DNA Sequencing
08/07/2026
Retrospective fragmentomics capability lets biopharma and academic researchers extract a second dimension of biology from archived liquid biopsy DNA sequencing data DURHAM, N.C., July 08, 2026 (GLOBE NEWSWIRE) -- [...]
Cannara Biotech Inc. annoncera ses résultats financiers pour le troisième trimestre de l'exercice 2026 le 15 juillet 2026
08/07/2026
MONTRÉAL, 08 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0) , producteur verticalement intégré de cannabis [...]
Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
08/07/2026
MONTREAL, July 08, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
International Gastroenterology Expert Working Group Publishes Consensus Framework for Improved Classification of Gastric Function in Patients with Chronic Stomach Conditions
08/07/2026
Neurogastroenterology & Motility paper describes the Auckland Classification, which is designed to bring clinical clarity to the hundreds of millions of patients worldwide The Auckland Classification, developed with [...]
FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
08/07/2026
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027 Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-label [...]
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
08/07/2026
SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results [...]
ORYZON Announces U.S. Patent Grant for Vafidemstat in Borderline Personality Disorder (BPD)
08/07/2026
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD U.S. patent to expire in March 2043, including 1,095 days of Patent Term Adjustment Notice of allowance also received in a [...]
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/07/2026
BRISBANE, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today [...]
Families Report Positive Outcomes From Fully Virtual, BCBA-Delivered, Focused Autism Support Program
08/07/2026
Study finds that fully virtual applied behavior analysis therapy conducted by BCBA clinicians at AnswersNow for autism support is feasible, well received by caregivers, and linked to positive outcomes for children and [...]

Pages